Glaxo seeks to block suit by jailed investigators
UK-based GlaxoSmithKline has asked a US court to compel arbitration of damages claims by the owners of a corporate intelligence firm who were convicted by Chinese authorities as part of the fallout from a corruption scandal that engulfed the pharmaceuticals group nearly five years ago.
To read more
Subscribe to Global Arbitration Review
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the Global Arbitration Review experts.